# FDA Inspection 1242919 - Hunan Dongting Pharmaceutical Co., Ltd. - May 24, 2024

Source: https://www.keypedia.com/records/fda_inspections/hunan-dongting-pharmaceutical-co-ltd/e060b7f3-82b2-4a0b-bf29-161d8f055d8c
Source feed: FDA_Inspections

> FDA Inspection 1242919 for Hunan Dongting Pharmaceutical Co., Ltd. on May 24, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1242919
- Company Name: Hunan Dongting Pharmaceutical Co., Ltd.
- Inspection Date: 2024-05-24
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 919451 - 2015-03-06](https://www.keypedia.com/records/fda_inspections/hunan-dongting-pharmaceutical-co-ltd/3188cf15-2b18-41da-aa37-9f3db44dbb45)
- [FDA Inspection 750577 - 2011-09-15](https://www.keypedia.com/records/fda_inspections/hunan-dongting-pharmaceutical-co-ltd/7a2c913c-b07d-46aa-93c0-4a9d86e159b4)

Company: https://www.keypedia.com/companies/hunan-dongting-pharmaceutical-co-ltd/e0b97214-0fd7-405c-bff0-ee949c6caa3e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c